Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

Summary

This study looks at the effect on basal and pentagastrin-stimulated acid output of 40 mg Esomeprazole (Nexium) administered orally and intravenously as a 15-minute infusion to people with symptoms of Gastroesophageal Reflux Disease (GERD)

Timeline

Start

2002-08

Primary completion

2002-10

Completion

2002-10

Drugs

Indications